These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30353872)

  • 1. Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics.
    Peng L; Parekh V; Huang P; Lin DD; Sheikh K; Baker B; Kirschbaum T; Silvestri F; Son J; Robinson A; Huang E; Ames H; Grimm J; Chen L; Shen C; Soike M; McTyre E; Redmond K; Lim M; Lee J; Jacobs MA; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1236-1243. PubMed ID: 30353872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases.
    Basree MM; Li C; Um H; Bui AH; Liu M; Ahmed A; Tiwari P; McMillan AB; Baschnagel AM
    J Neurooncol; 2024 Jun; 168(2):307-316. PubMed ID: 38689115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
    Zhang Z; Yang J; Ho A; Jiang W; Logan J; Wang X; Brown PD; McGovern SL; Guha-Thakurta N; Ferguson SD; Fave X; Zhang L; Mackin D; Court LE; Li J
    Eur Radiol; 2018 Jun; 28(6):2255-2263. PubMed ID: 29178031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.
    Leeman JE; Clump DA; Flickinger JC; Mintz AH; Burton SA; Heron DE
    Neuro Oncol; 2013 Dec; 15(12):1732-8. PubMed ID: 24243914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics Method for the Differential Diagnosis of Radionecrosis Versus Progression after Fractionated Stereotactic Body Radiotherapy for Brain Oligometastasis.
    Hettal L; Stefani A; Salleron J; Courrech F; Behm-Ansmant I; Constans JM; Gauchotte G; Vogin G
    Radiat Res; 2020 May; 193(5):471-480. PubMed ID: 32160109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps.
    Wang H; Xue J; Qu T; Bernstein K; Chen T; Barbee D; Silverman JS; Kondziolka D
    Med Phys; 2021 Sep; 48(9):5522-5530. PubMed ID: 34287940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.
    Minniti G; Clarke E; Lanzetta G; Osti MF; Trasimeni G; Bozzao A; Romano A; Enrici RM
    Radiat Oncol; 2011 May; 6():48. PubMed ID: 21575163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
    Stockham AL; Tievsky AL; Koyfman SA; Reddy CA; Suh JH; Vogelbaum MA; Barnett GH; Chao ST
    J Neurooncol; 2012 Aug; 109(1):149-58. PubMed ID: 22638727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric radiomic tissue signature and machine learning for distinguishing radiation necrosis from tumor progression after stereotactic radiosurgery.
    Chen X; Parekh VS; Peng L; Chan MD; Redmond KJ; Soike M; McTyre E; Lin D; Jacobs MA; Kleinberg LR
    Neurooncol Adv; 2021; 3(1):vdab150. PubMed ID: 34901857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment Spatially Aware Magnetic Resonance Imaging Radiomics Can Predict Distant Brain Metastases (DBMs) After Stereotactic Radiosurgery/Radiation Therapy (SRS/SRT).
    Bae J; Mani K; Zabrocka E; Cattell R; O'Grady B; Payne D; Roberson J; Ryu S; Prasanna P
    Adv Radiat Oncol; 2024 May; 9(5):101457. PubMed ID: 38550363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multidimensional Connectomics- and Radiomics-Based Advanced Machine-Learning Framework to Distinguish Radiation Necrosis from True Progression in Brain Metastases.
    Cao Y; Parekh VS; Lee E; Chen X; Redmond KJ; Pillai JJ; Peng L; Jacobs MA; Kleinberg LR
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases.
    Du P; Liu X; Xiang R; Lv K; Chen H; Liu W; Cao A; Chen L; Wang X; Yu T; Ding J; Li W; Li J; Li Y; Yu Z; Zhu L; Liu J; Geng D
    Eur Radiol; 2023 Dec; 33(12):8925-8935. PubMed ID: 37505244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning.
    Jaberipour M; Soliman H; Sahgal A; Sadeghi-Naini A
    Sci Rep; 2021 Nov; 11(1):21620. PubMed ID: 34732781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy.
    Buchner JA; Kofler F; Mayinger M; Christ SM; Brunner TB; Wittig A; Menze B; Zimmer C; Meyer B; Guckenberger M; Andratschke N; El Shafie RA; Debus J; Rogers S; Riesterer O; Schulze K; Feldmann HJ; Blanck O; Zamboglou C; Ferentinos K; Bilger-Zähringer A; Grosu AL; Wolff R; Piraud M; Eitz KA; Combs SE; Bernhardt D; Rueckert D; Wiestler B; Peeken JC
    Neuro Oncol; 2024 Sep; 26(9):1638-1650. PubMed ID: 38813990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery.
    Mouraviev A; Detsky J; Sahgal A; Ruschin M; Lee YK; Karam I; Heyn C; Stanisz GJ; Martel AL
    Neuro Oncol; 2020 Jun; 22(6):797-805. PubMed ID: 31956919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study.
    Dequesada IM; Quisling RG; Yachnis A; Friedman WA
    Neurosurgery; 2008 Nov; 63(5):898-903; discussion 904. PubMed ID: 19005380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of machine learning methods in delta-radiomics feature analysis.
    Chang Y; Lafata K; Sun W; Wang C; Chang Z; Kirkpatrick JP; Yin FF
    PLoS One; 2019; 14(12):e0226348. PubMed ID: 31834910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
    Kohutek ZA; Yamada Y; Chan TA; Brennan CW; Tabar V; Gutin PH; Yang TJ; Rosenblum MK; Ballangrud Å; Young RJ; Zhang Z; Beal K
    J Neurooncol; 2015 Oct; 125(1):149-56. PubMed ID: 26307446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.